OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL

Similar documents
Opioids Research to Practice

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Opioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Buprenorphine and MAT 101

MANAGING THE COSTS OF THE OPIOID EPIDEMIC IN WISCONSIN. State Senator Alberta Darling

Noel Schenk MD. Davis Behavioral Health

Opioids Research to Practice

Opioids Research to Practice

Opiate Use Disorder and Opiate Overdose

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

State Opioid Response (SOR) Grant

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville

Opioid Use Disorder Treatment Initiation in Diverse Settings

Medication Assisted Treatment for Opioid Use Disorders and Veteran Populations

Rationale & Strategy For Integrating Buprenorphine Treatment Into Community Health Centers

Acute General Medical and Surgical Admission:

Health Systems and Addiction: Provider Issues

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model

MGH Substance Use Disorder Initiative. Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP MGH ED Christopher Shaw, RN, ANP, PMHNP-BC, CARN-AP MGH ACT

1) To understand the scope of the opioid epidemic with relation to Emergency Departments 2) To gain insight into some emerging Emergency Medicine

Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

Treatment Issues: The Opiate Crisis Among Us

The Population is Abusing Drugs, but are Drugs Abusing Insurance?

Hospitals Role in Addressing the Opioid Crisis

Practical Tools to Successfully Taper Prescription Opioids. Melissa Weimer, DO, MCR

Opioid Dependence and Buprenorphine Management

Addiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer

Buprenorphine as a Treatment Option for Opioid Use Disorder

Medication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford

Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

Recommendations for Components of Emergency Department Discharge Protocols

It s Not Just One More Thing! Overcoming Obstacles for Buprenorphine Treatment by Residents, Faculty and Programs

Opioids Research to Practice

Fighting Today s Opioid Epidemic

Injectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP

Medication Assisted Treatment. Nicole Gastala, MD

AMBULATORY WITHDRAWAL MANAGEMENT

The Opioid Crisis: What Can Physicians Do About It?

State of Connecticut Department of Mental Health and Addiction Services. State Innovations in Prevention and Treatment of Opioid Use Disorders

Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine

Understanding and Combating the Heroin Epidemic

Opioid Overdose Education and Naloxone Distribution

Prepublication Requirements

Massachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs. Monica Bharel, MD MPH Commissioner of Public Health

Mass General s Substance Use Disorder Initiative

Patient and Family Agreement on Opioids

New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS

On the Frontlines of the Opioid Epidemic: Barriers and Challenges in the Emergency Department

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

Opioid use disorder: Supporting recovery with a medication-assisted treatment approach

Addressing the Opioid Epidemic in the Veterans Health Administration

Opioid Misuse and Overdose Prevention and Safety. Dr. Kathleen Clanon Medical Director May 31, 2018

The Unseen Consequences of Prescription Drug Abuse. Stephen Loyd, M.D.

2/7/2017. Avoid compassion traps. Avoid All or Nothing Traps. Some Explanatory Models of Addiction

Opioid Crisis, Our Response Massachusetts Coalition for the Prevention of Medical Errors. October 31, 2016

OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI)

Treatment of Pain in an Emergent Setting

Overdose Prevention: Empowering School Personnel & Families

Opioid dependence and buprenorphine treatment

Changing Course: statewide efforts to combat the opioid epidemic in California

Opioid Use in Youth. Amy Yule M.D. March 2,

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Opioid Use Disorders &Medication Treatment

GOALS AND OBJECTIVES

National Academy of Medicine Action Collaborative: Countering the US Opioid Epidemic

The Impaired Professional. Peter Cohen, D.O.

NBPDP Drug Utilization Review Process Update

Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Take Home Naloxone: What Pharmacists Need to Know

Update From OASAS Where are we and where are we going? Steven Kipnis MD, FACP, FASAM Medical Director, NYS OASAS

Expanding Access To Medication Assisted Treatment for Opioid Use Disorders to Patients in the Hospital

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Naloxone Statewide Standing Order. Cheryl A. Viracola, PharmD Pharmacy Programs Manager, Community Care of Wake and Johnston Counties

Report to The Vermont Legislature. Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

Managed Care Pushes for Safer Opioid Oversight

Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story

Vivitrol Vs. Suboxone

OPIOIDS: THE GOOD, THE BAD, AND EVERYTHING IN-BETWEEN

HOPE Agenda. Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN ASSEMBLY DISTRICT 89

Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic. October 25, 2017

The Opioid Crisis among the Privately Insured

Medical vs. Use of Drugs. Warning Signs of Chemical Dependence. Intent Effect. Legality Pattern 5/5/2010. Daily use above ceiling doses

2/21/2018. What are Opioids?

Safina Koreishi, MD, MPH, Medical Director, Columbia Pacific CCO

AMERICA S OPIOID EPIDEMIC AND ITS EFFECT ON THE NATION S COMMERCIALLY-INSURED POPULATION PUBLISHED JUNE 29, 2017

Management Options for Opioid Dependence:

Addicted, Alone, Forgotten, and Ashamed

The Opioid Epidemic: The State of the State

Naltrexone for Opioid Use Disorder. A Project RAMP Resource Adam J. Gordon, MD MPH FACP DFASAM CMRO December 2017

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

Taking suboxone with valium

Opioid Dependence 101 and Medication Assisted Treatment

The Importance of Psychological Treatment and Behavioral Support

Orange County Heroin Task Force Implementation Update. George Ralls M.D. Director of Health & Public Safety Orange County Government

Transcription:

OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL Brian Fuehrlein, MD PhD VA Connecticut Healthcare System and Yale University I have no conflicts of interest or relevant financial disclosures.

LEARNING OBJECTIVES To appreciate the magnitude of the opioid use disorder problem To understand various levels of care, using VA Connecticut as a model To understand the triaging of patients with opioid use disorders To understand the initiation of buprenorphine in a psychiatric emergency room setting

HEADLINES Panel approves anti-overdose legislation CT Post Heroin-related overdose deaths soar in CT Hartford Courant Opioid overdoses spiked again last year WTNH Conn News Summit held in New London to address heroin epidemic Fox 61 News Rep. Courtney seeking emergency money to fight opioid addiction, overdoses CT Mirror Pharmacists working to combat opioid overdose Uconn Today Drug overdoses keep rising in CT CT Post As opioid epidemic grows, Senator Murphy calls for improved access to buprenorphine treatment Stratford Star Senator Blumenthal issues Call to Action on opioid addiction CT post

OPIOID USE DISORDER Every day in the US, 44 people die as a result of prescription opioid overdose Drug overdose was the leading cause of injury death in 2013 (more than car accidents) 51.8% of overdose deaths involved opioids, 30.6% involved benzos In 2011, nearly 1 million ED visits were related to benzo and/or opioid misuse In 2013, nearly 2 million Americans either abused or were dependent on opioids In 2007, prescription opioid abuse costs were $55.7B http://www.cdc.gov/drugoverdose/

OPIOID USE DISORDER 581 males who met criteria for opioid use disorder were followed for 33 years (mean age 25.4 years) By 33 years (mean age 58.4 years), 49% had died, 6% incarcerated, 13% continued to use opioids, 23% were abstinent. Common causes of death: Homicide/suicide/accident, accidental overdose, chronic liver disease, cancer, heart disease Majority of deaths directly attributable to opioids Hser, et. al. A 33-Year Follow-up of Narcotic Addicts. Archives of General Psychiatry, 2001;58:503-508

OPIOID USE DISORDER A key driver of the overdose epidemic is underlying substance-use disorder. Consequently, expanding access to addiction-treatment services is an essential component of a comprehensive response. Volkow, Nora D., et al. "Medication-assisted therapies tackling the opioidoverdose epidemic." New England Journal of Medicine 370.22 (2014): 2063-2066.

OPIOID USE DISORDER Drug dependence generally has been treated as if it were an acute illness. Review results suggest that long-term care strategies of medication management and continued monitoring produce lasting benefits. Drug dependence should be insured, treated, and evaluated like other chronic illnesses. McLellan, A. Thomas, et al. "Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation." Jama 284.13 (2000): 1689-1695.

VA CONNECTICUT RESOURCES Psychiatric emergency room Inpatient Services Inpatient psychiatric unit Contracted detox facility Detox service (ambulatory and inpatient) Local inpatient substance abuse treatment facility Outpatient Services Substance abuse day program (PHP) Opioid treatment program (Methadone) Buprenorphine clinic Buprenorphine in primary care Outpatient substance abuse clinic Auricular acupuncture Various groups and therapy options AA/NA treatment referral

PSYCHIATRIC EMERGENCY ROOM Dedicated and locked unit, 24/7/365 One of only several nationally at a VA 10 beds with ability for extended observation, if necessary Patients may present voluntarily or involuntarily Most patients are observed overnight while disposition is being considered Patients occasionally spend more than one night in the PER when clinically appropriate Staffed by >30 MDs, all of whom required to have a buprenorphine waiver

BUPRENORPHINE Schedule 3, semi-synthetic opioid, partial agonist at mu-opioid receptor Available with or without naloxone Partial agonism creates ceiling effect for respiratory depression Generally once per day dosing Binds to the opioid receptor with high affinity

BUPRENORPHINE Induction Phase Assess last use of which opioid and how much Assess symptoms of withdrawal using COWS or other scale (COWS > 8) Do not dose with buprenorphine until withdrawal symptoms are present Once present, dose 2mg-4mg once then reassess in 1 hour Ok to redose, not to exceed 8mg on day 1 Do not exceed 16mg on day 2, which is usually sufficient Decide whether to maintain or taper/detox

D Onofrio, et. al. Emergency Department-Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence. JAMA; 2015:313(16):1636-1644

BUPRENORPHINE Eighty-nine of 114 patients (78%; 95% CI, 70%- 85%) in the buprenorphine group were engaged in treatment at significantly higher rates than the 38 of 102 patients (37%; 95% CI, 28%-47%) in the referral group or 50 of 111 patients (45%; 95% CI, 36%-54%) in the brief intervention group (P <.001). D Onofrio, et. al. Emergency Department-Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence. JAMA; 2015:313(16):1636-1644

LEVELS OF CARE Hold in psych ER Admit to the VA inpatient/detox service Transfer to contracted detox bed Refer to inpatient substance abuse treatment Refer to substance abuse day program Refer to opioid treatment program Refer to ambulatory detox team Refer to buprenorphine clinic Refer to outpatient clinic Refer to 90 in 90, sponsor, step work

CASE #1 25yo veteran presents to the PER seeking assistance with opioid use and sleep. He has no significant history of psychiatric or substance abuse treatment. Pt reports that 6 months ago he was prescribed an opioid for a shoulder injury. He realized that he started using the opioids to help him sleep and to get high. He started buying oxycodone on the street when he could no longer obtain prescriptions. He recently tried snorting though has never injected. He is currently using 1-2 times per week as that is all he can afford. He drinks alcohol occasionally. He wants to stop using opioids and is help-seeking.

LEVELS OF CARE Hold in psych ER Admit to the VA inpatient service Transfer to contracted detox bed Refer to inpatient substance abuse treatment Refer to substance abuse day program Refer to opioid treatment program Refer to ambulatory detox team Refer to buprenorphine clinic Refer to outpatient clinic Refer to 90 in 90, sponsor, step work

CASE #2 40yo male presents to the PER at the request of the buprenorphine clinic for continued opioid use. Pt reports that he has been on buprenorphine for 2 years and it has been very helpful. He admits to using occasional heroin off and on while on buprenorphine. He wishes to stay on buprenorphine. Pt has never been on methadone. He has been off buprenorphine for 2 weeks and last used IV heroin 5 days ago. Collateral from buprenorphine clinic reveals that they do not feel they can safely prescribe buprenorphine any longer.

LEVELS OF CARE Hold in psych ER Admit to the VA inpatient service Transfer to contracted detox bed Refer to inpatient substance abuse treatment Refer to substance abuse day program Refer to opioid treatment program Refer to ambulatory detox team Refer to buprenorphine clinic Refer to outpatient clinic Refer to 90 in 90, sponsor, step work

CASE #3 27yo veteran with a 5 year history of opioid use disorder. He presents to the psych ER seeking opioid detox. He has been injecting approximately 10 bags of heroin daily with his last use being yesterday morning. He has also been using xanax 1-2mg daily and drinking sporadically. He denies medical problems. His parents have threatened to evict him if he does not stop using. He is interested in detox but not treatment because he does not want to miss work. He denied psychiatric complaints.

LEVELS OF CARE Hold in psych ER Admit to the VA inpatient service Transfer to contracted detox bed Refer to inpatient substance abuse treatment Refer to substance abuse day program Refer to opioid treatment program Refer to ambulatory detox team Refer to buprenorphine clinic Refer to outpatient clinic Refer to 90 in 90, sponsor, step work

CASE #4 31yo presents to the PER seeking assistance with opioid use and suicidal thoughts. He has a history of 3 recent suicide attempts, one involving crashing his car into a tree. He also has a history of IV heroin use with multiple near overdoses, some intentional, some unintentional. He has been through the day program and the inpatient substance use program in the past. He has several inpatient psychiatric admissions as well. He has no medical problems. He is willing to be admitted for stabilization.

LEVELS OF CARE Hold in psych ER Admit to the VA inpatient service Transfer to contracted detox bed Refer to inpatient substance abuse treatment Refer to substance abuse day program Refer to opioid treatment program Refer to ambulatory detox team Refer to buprenorphine clinic Refer to outpatient clinic Refer to 90 in 90, sponsor, step work

CONCLUSION Psychiatric emergency rooms are often the point of entry for many opioid use disorder patients and serve as a referral source to various levels of care Community physicians should be aware of the resources available to their patients and be able to refer for proper treatment References: Hser, et. al. A 33-Year Follow-up of Narcotic Addicts. Archives of General Psychiatry, 2001;58:503-508 D Onofrio, et. al. Emergency Department-Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence. JAMA; 2015:313(16):1636-1644 Contact Information: Brian.fuehrlein@va.gov